Document Detail


A study of the effects of desipramine treatment alone and in combination with L-triiodothyronine on 6-sulphatoxymelatonin excretion in depressed patients.
MedLine Citation:
PMID:  2611544     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Urinary 6-sulphatoxymelatonin (alpha MT6s) excretion was measured after one day and one, two and three weeks of desipramine treatment in eight depressed patients. There was significant increase in the urinary excretion of alpha MT6s after one week of treatment, and at no time was there any decrease in alpha MT6s excretion. These findings are opposed to the hypothesis that desipramine reduces noradrenergic neurotransmission in the human pineal. In a further five patients whose depression was resistant to desipramine alone, urinary alpha MT6s excretion was measured during treatment with adjunctive L-triiodothyronine (T3). There was no change in alpha MT6s excretion, and thus the previously reported potentiation of the efficacy of tricyclic antidepressants in combination with T3 does not appear to be mediated through an alteration in noradrenergic neurotransmission.
Authors:
J Bearn; C Franey; J Arendt; S A Checkley
Related Documents :
3932134 - Excess dietary aluminum increases drosophila's rate of aging.
16520264 - High-sodium food choices by southern, urban african americans with heart failure.
3802724 - The potential use of lithium as a marker for the assessment of the sources of dietary s...
14682644 - Patterns of fluoride intake from 36 to 72 months of age.
16002194 - An in situ postexposure feeding assay with carcinus maenas for estuarine sediment-overl...
15869184 - Bioindicator organisms: heavy metal pollution evaluation in the ionian sea (mediterrane...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The British journal of psychiatry : the journal of mental science     Volume:  155     ISSN:  0007-1250     ISO Abbreviation:  Br J Psychiatry     Publication Date:  1989 Sep 
Date Detail:
Created Date:  1990-02-26     Completed Date:  1990-02-26     Revised Date:  2009-09-29    
Medline Journal Info:
Nlm Unique ID:  0342367     Medline TA:  Br J Psychiatry     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  341-7     Citation Subset:  IM    
Affiliation:
Institute of Psychiatry, University of Surrey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Depressive Disorder / drug therapy*,  urine
Desipramine / blood,  therapeutic use*
Drug Therapy, Combination
Female
Humans
Male
Melatonin / analogs & derivatives,  urine
Middle Aged
Time Factors
Triiodothyronine / therapeutic use*
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
2208-41-5/6-hydroxymelatonin; 50-47-5/Desipramine; 6893-02-3/Triiodothyronine; 73-31-4/Melatonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Socio-cultural parameters in Yoruba Nigerian patients with affective disorders.
Next Document:  The Scottish survey of new chronic in-patients: five-year follow-up.